Cite

HARVARD Citation

    Chadban, S. et al. (n.d.). A randomized, controlled trial of everolimus‐based dual immunosuppression versus standard of care in de novo kidney transplant recipients. Transplant international. pp. 302-311. [Online]. 
  
Back to record